BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 1356869)

  • 1. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
    Lundell L
    Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.
    Peters FT; Ganesh S; Kuipers EJ; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
    Gut; 1999 Oct; 45(4):489-94. PubMed ID: 10486353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
    Lambert R
    Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus.
    Wani S; Sampliner RE; Weston AP; Mathur S; Hall M; Higbee A; Sharma P
    Aliment Pharmacol Ther; 2005 Oct; 22(7):627-33. PubMed ID: 16181302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.
    Sontag SJ; Schnell TG; Chejfec G; Kurucar C; Karpf J; Levine G
    Aliment Pharmacol Ther; 1997 Feb; 11(1):147-56. PubMed ID: 9042987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus.
    Marshall RE; Anggiansah A; Manifold DK; Owen WA; Owen WJ
    Gut; 1998 Nov; 43(5):603-6. PubMed ID: 9824338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
    Basu KK; Bale R; West KP; de Caestecker JS
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
    Todd JA; Basu KK; de Caestecker JS
    Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
    Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
    Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term continuous omeprazole treatment of patients with Barrett's oesophagus.
    Neumann CS; Iqbal TH; Cooper BT
    Aliment Pharmacol Ther; 1995 Aug; 9(4):451-4. PubMed ID: 8527623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study.
    Moghissi K; Sharpe DA; Pender D
    Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's oesophagus: a clinical study of 52 patients.
    Cooper BT; Barbezat GO
    Q J Med; 1987 Feb; 62(238):97-108. PubMed ID: 3498962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflux strictures of the oesophagus in children: personal experience with preoperative dilatation followed by anterior funduplication.
    Briganti V; Oriolo L; Calisti A
    Pediatr Surg Int; 2003 Sep; 19(7):544-7. PubMed ID: 12961093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximal acid reflux control for Barrett's oesophagus: feasible and effective.
    Srinivasan R; Katz PO; Ramakrishnan A; Katzka DA; Vela MF; Castell DO
    Aliment Pharmacol Ther; 2001 Apr; 15(4):519-24. PubMed ID: 11284781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression.
    Fitzgerald RC; Lascar R; Triadafilopoulos G
    Aliment Pharmacol Ther; 2001 Mar; 15(3):269-76. PubMed ID: 11207503
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.